Bu2Sn(N-acetyl-L-cysteinate) antitumor activity on HepG2 cells
- Authors: Pellerito, C.; Prinzivalli, C.; Casella, G.; Fiore, T.; Pellerito, O.; Giuliano, M.; Scopelliti, M.; Pellerito, L.
- Publication year: 2010
- Type: Contributo in atti di convegno pubblicato in volume
- Key words: antitumor activity; HepG2 cells; organotin(IV)
- OA Link: http://hdl.handle.net/10447/65946
Abstract
Many drugs currently used in anticancer therapies, act by activating cytotoxic death by apoptosis. This death mechanism is often accompanied by mitochondrial events (intrinsic apoptosis) or the activation of death receptors (extrinsic pathway)
